Acorah Software Products - Accounts Production 19.1.200 false true 31 July 2024 1 August 2023 false 1 August 2024 31 July 2025 31 July 2025 11443145 Mr Romil Patel iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11443145 2024-07-31 11443145 2025-07-31 11443145 2024-08-01 2025-07-31 11443145 frs-core:ShareCapital 2025-07-31 11443145 frs-core:RetainedEarningsAccumulatedLosses 2025-07-31 11443145 frs-bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 11443145 frs-bus:AbridgedAccounts 2024-08-01 2025-07-31 11443145 frs-bus:SmallEntities 2024-08-01 2025-07-31 11443145 frs-bus:AuditExempt-NoAccountantsReport 2024-08-01 2025-07-31 11443145 frs-bus:SmallCompaniesRegimeForAccounts 2024-08-01 2025-07-31 11443145 frs-core:FurtherSpecificReserve1ComponentTotalEquity 2025-07-31 11443145 frs-bus:Director1 2024-08-01 2025-07-31 11443145 frs-countries:EnglandWales 2024-08-01 2025-07-31 11443145 2023-07-31 11443145 2024-07-31 11443145 2023-08-01 2024-07-31 11443145 frs-core:ShareCapital 2024-07-31 11443145 frs-core:RetainedEarningsAccumulatedLosses 2024-07-31 11443145 frs-core:FurtherSpecificReserve1ComponentTotalEquity 2024-07-31
Registered number: 11443145
Ellepharm Investments Limited
Unaudited ABRIDGED Financial Statements
For The Year Ended 31 July 2025
Ellepharm Investments Limited
Contents
Contents

| Page
--- | ---
Abridged Balance Sheet | 1—2
Notes to the Abridged Financial Statements | 3

Page 1
Ellepharm Investments Limited
Abridged Balance Sheet
As At 31 July 2025
Abridged Balance Sheet
Registered number: 11443145

| 2025 | 2024
--- | --- | ---
| Notes | £ | £ | £ | £
CURRENT ASSETS
Investments |  | 1,212,443 |  | 1,212,443 |
Cash at bank and in hand |  | 1 |  | 1 |
|  | 1,212,444 |  | 1,212,444 |
Creditors: Amounts Falling Due Within One Year |  | (2,520 ) |  | (2,160 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | 1,209,924 |  | 1,210,284
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 1,209,924 |  | 1,210,284
NET ASSETS |  |  | 1,209,924 |  | 1,210,284
CAPITAL AND RESERVES
Called up share capital | 4 |  | 101 |  | 101
Fair value reserve |  |  | 1,212,343 |  | 1,212,343
Profit and Loss Account |  |  | (2,520 ) |  | (2,160 )
SHAREHOLDERS' FUNDS |  |  | 1,209,924 |  | 1,210,284

Page 1
Page 2
Ellepharm Investments Limited
Abridged Balance Sheet (continued)
As At 31 July 2025
For the year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
All of the company's members have consented to the preparation of an Abridged Balance Sheet for the year end 31 July 2025 in accordance with section 444(2A) of the Companies Act 2006.
On behalf of the board

Mr Romil Patel Director
14 April 2026

The notes on page 3 form part of these financial statements.
Page 2
Page 3
Ellepharm Investments Limited
Notes to the Abridged Financial Statements
For The Year Ended 31 July 2025
Notes to the Abridged Financial Statements
1. General Information
Ellepharm Investments Limited is a private company, limited by shares, incorporated in England & Wales, registered number 11443145 . The registered office is 26 Station Road, Watford, Herts, WD17 1JU.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
3. Average Number of Employees
Average number of employees, including directors, during the year was:

| 2025 |  | 2024
--- | --- | --- | ---
Office and administration | 1 |  | 1
| 1 |  | 1

4. Share Capital

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 101 |  | 101

Page 3